Aktienanalyse zu Buda Juice Inc (BUDA)BUDABuda Juice Inc

Buda Juice, Inc. operates in a beverage industry, focused on UltraFresh juice-offering cold-crafted citrus-based drinks. The Company offers an end-to-end cold chain platform that always delivers cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. Its product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using its cold chain process. Its products include Buda Juice (Organic), Buda Fresh - Value-Forward Offering (Non-Organic), and Private Label Products (Non-organic and Organic). Buda Fresh includes Fresh 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice, Fresh Orange and Grapefruit Juice (16 oz, 32 oz and 52 oz), and Fresh Citrus-based Lemonades and Limeades (16 oz and 52 oz). Private Label Products include Fresh Citrus Line (52 oz) and Fresh Citrus-based Lemonades and Limeades (52 oz). It operates in the Consumer Non-Cyclicals sector.

Buda Juice appears to be a strong buy at the current price of $7.22, especially with an RSI of 62.22 indicating bullish momentum. The stock has a significant upside potential with an analyst price target of $12, suggesting a potential gain of 66.67%. Additionally, the company has shown robust revenue growth, with Q2 2026 revenue reaching $4.5 million, a substantial increase compared to previous quarters. However, investors should be cautious of the forward P/E ratio of 49.02, which indicates that the stock may be overvalued if growth does not meet expectations.